Skip to main content

Table 5 Multivariate analysis of DMFS on pretreatment quality of life of QLQ-C30 among 501 patients with nasopharyngeal carcinoma

From: Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT

 

HR

95%CI

P

Age

1.039

0.560–1.927

0.904

Gender

0.527

0.235–1.183

0.121

Marriage

3.217

0.669–15.479

0.145

Education

1.278

0.967–1.689

0.085

Smoking history

0.731

0.362–1.477

0.383

Alcohol history

0.882

0.342–2.271

0.794

T stage

1.305

0.611–2.787

0.491

N stage

2.251

1.212–4.179

0.010

Pre-treatment EBV DNA

1.730

0.963–3.109

0.067

Post-treatment EBV DNA

2.915

1.338–6.350

0.007

Pain

1.015

0.994–1.038

0.169

Felt ill

1.004

1.000–1.007

0.043

  1. Abbreviations: DMFS Distant metastasis free suvival, HR Harsard ratio
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us